To Access the Effects of Mucositis in Adults With Dental Implants (implantitis)
This study has been completed.
Information provided by:
First received: September 26, 2008
Last updated: September 29, 2010
Last verified: September 2010
Clinical research for the treatment of mucositis subjects who have dental implants for a minimum of one-year.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
|Official Title:||To Access the Effects of Mucositis in Adults With Dental Implants|
Resource links provided by NLM:
Further study details as provided by Colgate Palmolive:
Primary Outcome Measures:
- Bleeding on Probing [ Time Frame: 6 months ] [ Designated as safety issue: No ]Percentage of Bleeding Scale: The bleeding sites are identified by either a 0 or 1. (0=no bleeding & 1= bleeding) The number of spots between teeth that bleed are divided by number of spots between teeth that are scored.
- Mean Pocket Depth [ Time Frame: 6 Months ] [ Designated as safety issue: No ]Measurement scale: 0 millimeter measurement= no pocket depth. 3, 4, 5, & 6 millimeter are indications of deeper Pocket depth.
- Mean Percentage of Plaque Scores [ Time Frame: 6 Months ] [ Designated as safety issue: No ]Mean Percentage (%) of dental plaque on all tooth surfaces, including implants and natural teeth. Plaque Scale is 0=no plaque and 1= dental plaque present. Percentage is derived from sum of all plaque scores divided by the number of tooth surfaces scored.
|Study Start Date:||June 2007|
|Study Completion Date:||December 2007|
|Primary Completion Date:||December 2007 (Final data collection date for primary outcome measure)|
Experimental: Total toothpaste
Drug: Triclosan and Fluoride
Brush twice daily
Other Name: Total Toothpaste
Placebo Comparator: Ultrabrite toothpaste
Brush twice daily
Other Name: Ultrabrite toothpaste
Contacts and Locations